Recurrent Melanoma Completed Phase 2 Trials for Epacadostat (DB11717)

Also known as: Melanoma Recurrent

IndicationStatusPhase
DBCOND0028662 (Recurrent Melanoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01961115Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV MelanomaTreatment